Role of the University
The University of Cambridge has the third most successful university innovation ecosystem in the world behind Stanford and Massachusetts Institute of Technology (MIT Skoltech Initiative Report 2014). The city has been incredibly successful in establishing, nurturing and growing spin-outs from the colleges.
Cambridge University Computer Lab alumni have accounted for over 240 companies alone. Also, recent statistics have shown that the follow-on funding for the University of Cambridge spin-outs has amounted to £1.4 billion. However, there is more that can come from this and the comparison to MIT, with around 11,000 students, shows the potential achievable scale within an appropriate funding environment. A 2011 survey of living MIT alumni found they have formed 25,800 companies and had revenues over £1.2 trillion per annum. This revenue is only 20% less than the UK’s total GDP in 2015.
Beyond Cambridge
The ‘research triangle’ is important but a linear axis of bioscience has emerged between Cambridge, through Hertfordshire and into London, specifically around King’s Cross and the Euston Road, where medical research clustering is significant.
South Cambridgeshire remains the most concentrated for the life science sector in the UK and a major cluster in Europe. The strength of this cluster will support further related development to the south of the city.
However, competitive locations exist throughout the UK. Reading, for example, remains the UK number one technology cluster, based upon the number of companies, with one in five enterprises being tech sector companies, more than three times the national average according to KPMG. Of course, Cambridge remains the major bioscience cluster.
Office/R&D property market
Cambridge benefits from the two main sectors of technology and bioscience “colliding”. The shift to bioinformatics and the computer modelling of drug discovery places Cambridge in a sweet spot of growth, ahead of the rest of the UK and potentially Europe.
Where is this best accommodated, encouraged and/or developed further? Constraining factors for Cambridge will include the affordability of commercial floorspace.
While uncertainty over Brexit has prompted a slowdown in leasing activity so far this year, the mismatch of supply and demand remains. There is currently anticipated requirement from more than a dozen companies looking for more than approximately 50,000 sq ft each.
For occupiers wanting even more space, only design and build options are available. This entails a wait of around two to three years for the development to emerge which may prompt the company to seek space in competing cities.
Demand from smaller startups and incubator-style occupiers within Cambridge remains resilient and specialist pioneering research in the life science sector has led to pharmaceutical companies and technology firms aggressively acquiring companies and growing.
At the same time, a number of established Cambridge and international names are continuing to expand within the city as their business needs change.
Most notably, we have seen a shift in bioscience companies clustering south of the city, with the Science Park continuing to also attract these uses as well as technology firms. AstraZeneca have committed to a complex of circa 850,000 sq ft at the Biomedical Campus to be operational by 2017, and recently acquired a further 55,000 sq ft of office space in the city centre as well as space at Cambridge Science Park and more recently at Chesterford Research Park.
Most recently, Illumina have committed to 150,000 sq ft of offices and laboratory accommodation at Granta Park, and Gilead are on-site at Granta Park building out 100,000 sq ft. Without matching supply, availability of space is set to fall by 90% from end-2012 to end-2017 (see Figure 1 above).
The northern side of Cambridge, with the Science Park, Cambridge Business Park and St John’s Innovation Park, remains the area of highest density of office and R&D occupiers within the City. There remain few commercial development plots suitable or capable of housing significant development.